PMC:7283670 / 62499-62678 JSONTXT

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T581","span":{"begin":168,"end":172},"obj":"http://purl.obolibrary.org/obo/CLO_0001302"}],"text":"Experimental: demdesivir (RDV), 5 days participants will receive continued standard of care therapy together with RDV 200 mg on Day 1 followed by RDV 100 mg on Days 2, 3, 4, and 5"}

{"project":"LitCovid-PubTator","denotations":[{"id":"1889","span":{"begin":39,"end":51},"obj":"Species"}],"attributes":[{"id":"A1889","pred":"tao:has_database_id","subj":"1889","obj":"Tax:9606"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Experimental: demdesivir (RDV), 5 days participants will receive continued standard of care therapy together with RDV 200 mg on Day 1 followed by RDV 100 mg on Days 2, 3, 4, and 5"}